VISIOMED GROUP (ALVMG.PA)
FR0013481835 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.23M | 2.36M | 6.57M | 779.00K | 6.47M | |||
| Cash Equivalents | N/A | N/A | 7.00K | 31.00K | 415.00K | |||
| Receivables | 3.98M | 3.98M | 6.50M | 2.70M | 2.42M | |||
| Inventories | 0.00 | 658.00K | 1.43M | 1.34M | 3.07M | |||
| Other Current Assets | N/A | 1.00K | 1.49M | 222.00K | 886.00K | |||
| Total Current Assets | 6.21M | 7.00M | 15.99M | 5.08M | 13.27M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.66M | 8.59M | 4.98M | 302.00K | 557.00K | |||
| Investments And Advances | 1.20M | 1.17M | 1.11M | 210.00K | 338.00K | |||
| Goodwill | 18.95M | 18.95M | 21.90M | 223.00K | 273.00K | |||
| Intangibles | 328.00K | 374.00K | 89.00K | 97.00K | 535.00K | |||
| Other Non-Current Assets | 1.00K | -1.00K | N/A | N/A | -237.00K | |||
| Total Non-Current Assets | 29.14M | 29.09M | 28.08M | 832.00K | 1.47M | |||
| TOTAL ASSETS | 35.35M | 36.09M | 44.07M | 5.91M | 14.73M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 2.00K | 4.00K | |||
| Accrued Expenses | 981.00K | 1.12M | 1.96M | 3.50M | 5.75M | |||
| Accounts Payable | 2.42M | 2.96M | 4.34M | 5.21M | 7.37M | |||
| Other Current Liabilities | 250.00K | 1.31M | 14.09M | 477.00K | 899.00K | |||
| Total Current Liabilities | 3.65M | 5.39M | 20.39M | 9.19M | 14.02M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 8.16M | 5.62M | 4.95M | 11.00K | 3.02M | |||
| Deferred Taxes/Income | N/A | N/A | 17.00K | N/A | N/A | |||
| Other Non-Current Liabilities | 699.00K | 803.00K | 4.64M | 1.12M | 2.80M | |||
| Total Non-Current Liabilities | 8.86M | 6.42M | 9.61M | 1.13M | 5.82M | |||
| TOTAL LIABILITIES | 12.51M | 11.81M | 29.99M | 10.32M | 19.84M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -10.26M | -8.81M | -4.70M | -31.22M | -25.09M | |||
| Additional Paid In Capital | 30.15M | 30.14M | 17.11M | 6.05M | 8.49M | |||
| Minority Interest | 0.00 | 0.00 | N/A | N/A | 316.00K | |||
| Common Shares | 2.94M | 2.94M | 1.38M | 20.33M | 11.49M | |||
| Other Shareholders' Equity | N/A | -1.00K | 280.00K | 430.00K | -2.00K | |||
| Shares Outstanding | 294.27M | 294.27M | 138.09M | 25.38M | 14.35M | |||
| Tangible Book Value per Share | 0.01 | 0.02 | -0.06 | -0.19 | -0.41 | |||
| Total Shareholders' Equity | 22.84M | 24.27M | 14.07M | -4.41M | -5.11M | |||
| TOTAL LIABILITIES AND EQUITY | 35.35M | 36.09M | 44.07M | 5.91M | 14.73M | |||
| Statistics | ||||||||
| Debt/Equity | 0.36 | 0.23 | 0.35 | -0.00 | -0.59 | |||
| Current Ratio | 1.70 | 1.30 | 0.78 | 0.55 | 0.95 | |||
| Return On Assets (ROA) | -10.01% | -14.62% | -10.11% | -87.16% | -163.28% | |||
| Return On Equity (ROE) | -15.50% | -21.74% | -31.67% | N/A | N/A | |||
All data in EUR